FDA.reportPublic FDA data

ELIPHOS Tablets 667 MG (Ca 169 MG) Oral Tablet

RxCUI
830642
RxNorm name
ELIPHOS Tablets 667 MG (Ca 169 MG) Oral Tablet
Display name
ELIPHOS Tablets 667 MG (Ca 169 MG) Oral Tablet
Full name
ELIPHOS Tablets 667 MG (Ca 169 MG) Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9fc1ada4-9ef4-48e9-8203-32aa857d0429ELIPHOS Tablets 667 MG (Ca 169 MG) Oral Tablet [PSN] · calcium acetate 667 MG Oral Tablet [Eliphos] [SBD] · Eliphos Calcium Acetate 667 (Calcium 169 MG) Oral Tablet [SY]33These highlights do not include all the information needed to use ELIPHOS ® Tablets safely and effectively. See full prescribing information for ELIPHOS ® Tablets. ELIPHOS ® Tablets (calcium acetate): 667 mg Initial U.S. Approval: 199020160806